Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals


INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.

 Chart
2012
2013
Revenue
Revenue
5,2665,963
Cost of revenue
Cost of revenue
-2,172-1,650
Gross Profit
Gross Profit
3,094
4,313
Sales, general & ad...
Sales, general and administrative
-2,435-2,883
Depreciation
Depreciation and amortization
-240-258
Provision
Provision
00
Other op inc/exp...
Other operating income/expenses
00
Operating income
Operating income EBIT
420
1,172
 
   
Interest expense
Interest expense
-17726
Other income/exp...
Other income(expense)
474-50
Profit before tax
Profit before tax
717
1,148
Income tax & other ta...
Income tax and other taxes
207342
Net income from c...
Net income from continuing operations
510806
Extraordinary & disc...
Extraordinary items & Discontinued Ops
00
Share of associates
Share of associates
00
Minority Interest
Minority Interest
00
Net Income
Net income
510
806
 
   
NI - Preferred Di...
Net Income after Preferred Dividend and Others
510806
Basic shares
Basic shares
158158
Diluted Shares
Diluted Shares
158158
EPS Basic
EPS Basic in Rupees
3.225.09
EPS Diluted
EPS Diluted in Rupees
3.22
5.09